SCHEMBL22741147

SCHEMBL22741147

c1ccc2c(c1)c1ccccc1n2-c1ccc2cc3c(cc2c1)oc1cc2oc4cc5cc(-n6c7ccccc7c7ccccc76)ccc5cc4c2cc13

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.42
▸ ATM Q13315 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ MAOA P21397 1/20 0.34
▸ F2 P00734 1/20 0.34
▸ F10 P00742 1/20 0.34
▸ PRSS1 P07477 1/20 0.34
▸ PRKDC P78527 4/20 0.33
▸ AHR P35869 2/20 0.33
▸ XRCC6 P12956 1/20 0.33
▸ XRCC5 P13010 1/20 0.33
▸ PTPN1 P18031 2/20 0.32
▸ ALDH2 P05091 1/20 0.31
▸ NPC1 O15118 2/20 0.31
▸ ALDH1A1 P00352 2/20 0.31
▸ RAB9A P51151 2/20 0.31
▸ SMN1; SMN2 Q16637 2/20 0.31
▸ PMM2 O15305 1/20 0.31
▸ MPI P34949 1/20 0.31
▸ PHOSPHO1 Q8TCT1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22741355 0.95 KDM4E (0.43) KDM4EATML3MBTL1F2F10
SCHEMBL19636266 0.90 KDM4E (0.39) KDM4EATML3MBTL1F2F10
SCHEMBL22742886 0.90 KDM4E (0.41) KDM4EATML3MBTL1F2F10
SCHEMBL22741465 0.88 KDM4E (0.40) KDM4EATML3MBTL1F2F10
SCHEMBL17446012 0.86 AHR (0.38) KDM4EATML3MBTL1MAOAF2
SCHEMBL22740487 0.85 KDM4E (0.35) KDM4EATML3MBTL1F2F10
SCHEMBL22742620 0.85 KDM4E (0.35) KDM4EATML3MBTL1F2F10
SCHEMBL12811339 0.84 KDM4E (0.47) KDM4EATML3MBTL1MAOAAHR
SCHEMBL9890313 0.84 KDM4E (0.47) KDM4EATML3MBTL1MAOAAHR
SCHEMBL22260458 0.84 KDM4E (0.36) KDM4EATML3MBTL1F2F10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200377513-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2020-12-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200377513-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE PIEZO1, TMEM109, LEF1 KDM4E 3079/4885ATM 2818/4885L3MBTL1 2417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback